Paper · 35453733
Induction of Stem-Cell-Derived Cardiomyogenesis by Fibroblast Growth Factor 10 (FGF10) and Its Interplay with Cardiotrophin-1 (CT-1).
Khosravi F and 3 others. Biology (Basel), 2022. Cited by 4 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Induction of Stem-Cell-Derived Cardiomyogenesis by Fibroblast Growth Factor 10 (FGF10) and Its Interplay with Cardiotrophin-1 (CT-1). Papers, record 35453733. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35453733
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Induction of Stem-Cell-Derived Cardiomyogenesis by Fibroblast Growth Factor 10 (FGF10) and Its Interplay with Cardiotrophin-1 (CT-1).
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 11/2020 GI | Universitätsklinikum Gießen und Marburg | PubMed |
Source PubMed
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References30
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28,596,337 | Cardiac regeneration strategies: Staying young at heart. | Science | 2017 | https://conductscience.org/library/papers/28596337 | PubMed |
| 2 | 27,184,924 | Catheter-based Intramyocardial Injection of FGF1 or NRG1-loaded MPs Improves Cardiac Function in a Preclinical Model of Ischemia-Reperfusion. | Sci Rep | 2016 | https://conductscience.org/library/papers/27184924 | PubMed |
| 3 | 10,477,538 | Involvement of cardiotrophin-1 in cardiac myocyte-nonmyocyte interactions during hypertrophy of rat cardiac myocytes in vitro. | Circulation | 1999 | https://conductscience.org/library/papers/10477538 | PubMed |
| 4 | 28,684,531 | Cardiomyocyte Regeneration: A Consensus Statement. | Circulation | 2017 | https://conductscience.org/library/papers/28684531 | PubMed |
| 5 | 16,687,131 | Congenital heart defects in Fgfr2-IIIb and Fgf10 mutant mice. | Cardiovasc Res | 2006 | https://conductscience.org/library/papers/16687131 | PubMed |
| 6 | 17,607,356 | Wnt/beta-catenin signaling promotes expansion of Isl-1-positive cardiac progenitor cells through regulation of FGF signaling. | J Clin Invest | 2007 | https://conductscience.org/library/papers/17607356 | PubMed |
| 7 | 30,030,417 | Early Regenerative Capacity in the Porcine Heart. | Circulation | 2018 | https://conductscience.org/library/papers/30030417 | PubMed |
| 8 | 25,914,893 | FGF10 Signaling Enhances Epicardial Cell Expansion during Neonatal Mouse Heart Repair. | J Cardiovasc Dis Diagn | 2013 | https://conductscience.org/library/papers/25914893 | PubMed |
| 9 | 17,045,289 | High- but not low-molecular weight FGF-2 causes cardiac hypertrophy in vivo; possible involvement of cardiotrophin-1. | J Mol Cell Cardiol | 2007 | https://conductscience.org/library/papers/17045289 | PubMed |
| 10 | 17,032,753 | FGF1/p38 MAP kinase inhibitor therapy induces cardiomyocyte mitosis, reduces scarring, and rescues function after myocardial infarction. | Proc Natl Acad Sci U S A | 2006 | https://conductscience.org/library/papers/17032753 | PubMed |
1 to 10 of 30
See all 30 referencesCited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37,997,983 | Editorial: Special Issue-Understanding and Targeting Heart Failure: From Biology to Therapeutics. | Biology (Basel) | 2023 | https://conductscience.org/library/papers/37997983 | PubMed |
| 36,204,584 | Coronary artery disease risk factors affected by RNA modification-related genetic variants. | Front Cardiovasc Med | 2022 | https://conductscience.org/library/papers/36204584 | PubMed |
| 36,124,135 | Phenotypic spectrum of FGF10-related disorders: a systematic review. | PeerJ | 2022 | https://conductscience.org/library/papers/36124135 | PubMed |
Genes27
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ACTN1 | 87 | PubTator's text mining | https://conductscience.org/library/genes/87 | NCBI Gene |
| AKT1 | 207 | PubTator's text mining | https://conductscience.org/library/genes/207 | NCBI Gene |
| AURKB | 9,212 | PubTator's text mining | https://conductscience.org/library/genes/9212 | NCBI Gene |
| CDKN1B | 1,027 | PubTator's text mining | https://conductscience.org/library/genes/1027 | NCBI Gene |
| CTF1 | 1,489 | PubTator's text mining | https://conductscience.org/library/genes/1489 | NCBI Gene |
| CTNNB1 | 1,499 | PubTator's text mining | https://conductscience.org/library/genes/1499 | NCBI Gene |
| FGF1 | 2,246 | PubTator's text mining | https://conductscience.org/library/genes/2246 | NCBI Gene |
| FGF10 | 2,255 | PubTator's text mining | https://conductscience.org/library/genes/2255 | NCBI Gene |
| FGF2 | 2,247 | PubTator's text mining | https://conductscience.org/library/genes/2247 | NCBI Gene |
| FGF3 | 2,248 | PubTator's text mining | https://conductscience.org/library/genes/2248 | NCBI Gene |
1 to 10 of 27
See all 27 genesDrugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35453733
GET https://conductscience.org/api/papers/v1/35453733/references?page=2